Global Genetic Toxicology Testing Market Size, Trends and Analysis - Forecasts to 2026 By Product (Assays, Services), By Application (Healthcare Industry, Food Industry, Cosmetic Industry, Other Industries), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis and Competitor Analysis
Genetic toxicology tests are undertaken to either know the chromosomal damage or the gene mutation. Genotoxicity can be understood through the infliction of genetic information by harmful substances. Genetic toxicology testing is conducted on pharmaceutical ingredients, industrial chemicals, pharmaceutical impurities, agrochemicals, and chemicals used in the cosmetic industry. As the need for sterile pharmaceutical drugs and equipment increases among the end-users of pharmaceutical products, the more demand potential it creates for the genetic toxicology testing market.
Market portfolio can be further elucidated by the presence of regulatory authorities- OECD Expert Working Groups and Genetic Toxicology Association that strengthens the market performance. Rapid advancements in sequencing technology also push the market demand in a positive direction. Genetic toxicology tests are required for drug developments to ensure safe drug consumption and given the rising drug development market in Europe, North America, and the Asia Pacific, such factors and requirements will place the market on a competitive front. As for technological trends, the market is enhanced by the emergence of automated analyses, genomics, and in vivo monitoring technologies. The establishment of new regulations (reduced animal tests) and new standards to the toxicology helps to accentuate the market growth in the aforementioned period.
Based on the product, the market considers assays and services into account. The assays division of the market would have a large market share owing to the arrival of technologies in the assay market. The emergence of cell-based assays is dominating the market space adding to the high market growth for the mentioned period. Manufacturers operating in the testing domain adhere to strict regulations and also perform distinctive assays. Also, the preference of in vitro cytotoxicity assays over the testing of animals enhances the market potential.
Based on the application, market studies cosmetic, healthcare, and food industry among others. The cosmetic industry would have the highest market use for toxicology testing. The dominating cosmetic market of Europe, an inclined trend towards animal-free testing, and rising validation of in vitro tests will lead to the better market potential of toxicology tests in the cosmetic industry.
Based on the region, the market analyses Asia Pacific to be a leading region in the market. Fast developments and gaining popularity of genetic testing in the region, rising healthcare industry and non-cruelty free testing leads to the genetic toxicology testing domain to grow in the region.
Key players operating in the market include are Covance, Eurofins Scientific, Charles river, BioReliance, Fraunhofer ITEM, Instem, Gentronix Ltd, Merck KGaA, and Thermo Fisher Scientific among others
Please note: This is not an exhaustive list of companies profiled in the report.
In May 2020, Thermo Fisher Scientific announced to acquire Qiagen to focus on genetic disorders and the cancer treatment market.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Genetic Toxicology Testing Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Genetic Toxicology Testing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?